STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
At the ASCO annual meeting, Bristol-Myers Squibb presented positive data regarding its treatment for multiple myeloma. Meanwhile, Pfizer showcased promising results for its lung cancer therapy. These developments highlight ongoing advancements in cancer treatment and drug development.
- ▪Bristol-Myers Squibb reported positive data for its multiple myeloma treatment at ASCO.
- ▪Pfizer presented encouraging results for its lung cancer therapy during the conference.
- ▪The ASCO annual meeting serves as a significant platform for cancer research advancements.
STAT News files mainly under health. We currently carry 235 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | STAT News |
| Canonical URL | https://www.statnews.com/2026/05/29/asco-news-day-1-multiple-myeloma-bristol-lung-cancer-pfizer/?utm_campaign=rss |
| Publication time | Fri, 29 May 2026 21:32:26 +0000 |
| Retrieval time | 2026-05-29T21:50:35.556Z |
| Last seen | 2026-05-29T21:50:35.556Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | HNZe6-d17Psu |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
STAT PlusHealth At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer Manage alerts for this article Email this article Share this article Chicago, where thousands in the cancer world gather each year.Adam Feuerstein/STAT By Adam Feuerstein, Matthew Herper, and Angus ChenMay 29, 2026 Adam Feuerstein[email protected]Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at STAT News.
Discussion
0 commentsMore from STAT News
